EP 1506314 A4 20050824 - COMPLEMENT MEDIATED ASSAYS FOR IN VIVO AND IN VITRO METHODS
Title (en)
COMPLEMENT MEDIATED ASSAYS FOR IN VIVO AND IN VITRO METHODS
Title (de)
KOMPLEMENT-VERMITTELTE ASSAYS FÜR VERFAHREN IN VIVO UND IN VITRO
Title (fr)
ESSAIS A MEDIATION PAR COMPLEMENT POUR DES PROCEDES IN VIVO ET IN VITRO
Publication
Application
Priority
- US 0216302 W 20020522
- US 29261601 P 20010522
- US 29732101 P 20010611
- US 32402901 P 20010921
Abstract (en)
[origin: WO03063763A2] The present invention is directed to methods and compositions for detection of target analytes, comprising proteins and nucleic acids, in multiple cellular compartments. Preferred embodiments comprise the use of complement-mediated assays and complement mediated treatments for human and animals. Methods and compositions for monitoring multiple stages of disease and infection are presented.
IPC 1-7
IPC 8 full level
G01N 33/53 (2006.01); G01N 33/574 (2006.01)
CPC (source: EP)
A61K 35/18 (2013.01); G01N 33/564 (2013.01); G01N 33/569 (2013.01); G01N 33/57492 (2013.01)
Citation (search report)
- [PX] WO 0156456 A2 20010809 - CYGENE INC [US], et al
- [X] CARDONE F ET AL: "A role for complement in transmissible spongiform encephalopathies.", NATURE MEDICINE. APR 2001, vol. 7, no. 4, April 2001 (2001-04-01), pages 410 - 411, XP002314397, ISSN: 1078-8956
- See references of WO 03063763A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 03063763 A2 20030807; WO 03063763 A3 20041209; AU 2002365902 A1 20030902; CA 2447892 A1 20030807; EP 1506314 A2 20050216; EP 1506314 A4 20050824; JP 2005516198 A 20050602
DOCDB simple family (application)
US 0216302 W 20020522; AU 2002365902 A 20020522; CA 2447892 A 20020522; EP 02806678 A 20020522; JP 2003563459 A 20020522